Ledger entry · candidate
Canagliflozin → Fungal infection — Audit-grade candidate (class scan)
Drug: canagliflozin · AE: Fungal infection
Discovered via class scan of SGLT2 inhibitors. PRR = 31.49, n = 1423 cases.
Disproportionality
- PRR: 31.488676573879786
- Yates χ2: n/a
- Cases (case-drug + AE): n = 1423
- Verdict:
PASSES_ALL_GATES — PRR=31.49 (95% CI 29.91–33.16), n=1423 cases; flagged for clinical expert review, NOT for external escalation without manual verification
Top reactions in cohort
| MedDRA PT | n |
|---|
| No reactions surfaced in cohort. |
Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.